AVITA Medical, Inc. (NASDAQ: RCEL) reported Q1 EPS of ($0.73), $0.41 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $11.1 million versus the consensus estimate of $12.02 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.